Medpho Raises $1 Mn From Cygnus Medicare Group And Others The startup aims to focus on strengthening the company's position in the market, expansion, innovation and provide complete healthcare services to rural and urban consumers

By Prabhjeet Bhatla

Opinions expressed by Entrepreneur contributors are their own.

You're reading Entrepreneur India, an international franchise of Entrepreneur Media.

Medpho

Healthcare technology startup Medpho, on Tuesday, announced that it raised $1 million in an Angel funding round led by Cygnus Medicare Group, Probal Ghoshal, chairman, Amar Ujala; Dr. Shuchin Bajaj, founder and director, Ujala Cygnus and Raghavendra Prasad, founder, Project StepOne.

With the funding, the startup aims to focus on strengthening the company's position in the market, expansion, innovation and provide complete healthcare services to rural and urban consumers.

"We are fortunate to find investors who believe in Medpho's vision, and backed us on this novel project. We will be utilizing the investments to expand our team and scale up our technologies and product innovations. Through our strategic alliances, technological advancements and offerings we want to create a value-based healthcare brand for communities with an emphasis on affordability and convenience," said Shashank Saini, founder, Medpho.

Medpho is a digital health startup founded by Shashank Saini in October 2020, aiming to disrupt the current healthcare industry by being a one-point solution for all essential healthcare needs for consumers. The startup provides unlimited telephonic consultation for a lifetime with zero wait time to all the communities. Medpho has impacted 1 lakh plus lives so far. With its online and offline services, the company offers the consumers an integrated solution for connecting to doctors, pharmacies, ambulances, medical equipment and diagnostic services. Medpho has partnered with more than 600 doctors and over 100 supply partners to facilitate medical services, medicine delivery and diagnostic services.

"We believe Medpho with its affordable and quality healthcare services will create a high impact on the Indian healthcare ecosystem. To transform the healthcare industry, it is important to identify grassroots changemakers and back them with sufficient resources. Medpho is one of the key players in the foundation of a robust healthcare system in India with its nucleus of providing affordable and accessible medical care across the country," added Dr Shuchin Bajaj, founder director, Cygnus Medicare Group.

Medpho's customers include the Sequoia Capital India LLP, British High Commission, Midland Credit Management India, Crown Plaza Hotel & Resorts, Shoppers Stop Ltd. etc. They also work with Government bodies in providing last-mile healthcare services such as Teleconsultation, medicine delivery, and building COVID care centres and manpower supply (paramedics and nurses).

Prabhjeet Bhatla

Former Staff

Business Ideas

70 Small Business Ideas to Start in 2025

We put together a list of the best, most profitable small business ideas for entrepreneurs to pursue in 2025.

Business News

Over 1,300 Google Employees Have Signed a New Petition Asking For Job Security

Google laid off thousands of employees in the past two years, which has left some employees feeling insecure about keeping their jobs.

News and Trends

Religion-Tech Startup Utsav and Road Safety Pioneer Prismoline Raise Funding

The following Indian startups have announced details of their recent investment rounds.

News and Trends

Chennai-Based Peaceful Progress Fund Eyes Innovation with INR 50 Cr First Close

The fund plans to invest in 25+ startups over three years, focusing on AI, IoT, FMCG, EVs, drones, and spacetech across tech and non-tech sectors.

News and Trends

Trifecta Capital Announces First Close of INR 2,000 Cr Fourth Venture Debt Fund

With the fourth fund, Trifecta Capital aims to invest in over 100 companies across fintech, EVs, logistics, and core tech, while exploring emerging sectors like renewable energy, climate, and sustainability for future growth.